DK1706121T3 - Dk/ep - Google Patents

Dk/ep

Info

Publication number: DK1706121T3
Authority: DK; Denmark
Prior art keywords: compounds; endopeptidase; hsep; benzoxazepine; benzothiazepine
Prior art date: 2004-01-12

Application number

DK05701469T

Other languages

Danish (da)

English (en)

Inventor

Michael Weske

Lechoslaw A Turski

Hrissanthi Ikonomidou

Dieter Ziegler

Original Assignee

Solvay Pharm Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-12

Filing date

2005-01-10

Publication date

2009-01-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34796705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1706121(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-01-10 Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv

2009-01-05 Application granted granted Critical

2009-01-05 Publication of DK1706121T3 publication Critical patent/DK1706121T3/da

Links

102000003729 Neprilysin Human genes 0.000 abstract 2
108090000028 Neprilysin Proteins 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
ZCXLTWVZYXBHJS-UHFFFAOYSA-N 1,2-benzoxazepine Chemical class O1N=CC=CC2=CC=CC=C12 ZCXLTWVZYXBHJS-UHFFFAOYSA-N 0.000 abstract 1
DQFQCHIDRBIESA-UHFFFAOYSA-N 1-benzazepine Chemical class N1C=CC=CC2=CC=CC=C12 DQFQCHIDRBIESA-UHFFFAOYSA-N 0.000 abstract 1
QJJDBWAEIBNZPQ-UHFFFAOYSA-N 2-(3h-1,2-benzothiazepin-2-yl)acetic acid Chemical class S1N(CC(=O)O)CC=CC2=CC=CC=C21 QJJDBWAEIBNZPQ-UHFFFAOYSA-N 0.000 abstract 1
102000005593 Endopeptidases Human genes 0.000 abstract 1
108010059378 Endopeptidases Proteins 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
-1 phosphono-substituted benzazepinone Chemical class 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

DK05701469T 2004-01-12 2005-01-10 Dk/ep DK1706121T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US53553804P	2004-01-12	2004-01-12
EP04100067		2004-01-12
PCT/EP2005/050075 WO2005067937A1 (en)	2004-01-12	2005-01-10	Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders

Publications (1)

Publication Number	Publication Date
DK1706121T3 true DK1706121T3 (da)	2009-01-05

Family

ID=34796705

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05701469T DK1706121T3 (da)	2004-01-12	2005-01-10	Dk/ep

Country Status (22)

Country	Link
EP (1)	EP1706121B1 (pl)
JP (1)	JP4951350B2 (pl)
KR (1)	KR101219580B1 (pl)
CN (1)	CN101076339B (pl)
AT (1)	ATE406899T1 (pl)
AU (1)	AU2005205067B2 (pl)
BR (1)	BRPI0506750A (pl)
CA (1)	CA2551789C (pl)
CY (1)	CY1108588T1 (pl)
DE (1)	DE602005009487D1 (pl)
DK (1)	DK1706121T3 (pl)
ES (1)	ES2313279T3 (pl)
HR (1)	HRP20080611T3 (pl)
IL (1)	IL176456A (pl)
NO (1)	NO20063623L (pl)
PL (1)	PL1706121T3 (pl)
PT (1)	PT1706121E (pl)
RU (1)	RU2362563C2 (pl)
SI (1)	SI1706121T1 (pl)
UA (1)	UA82008C2 (pl)
WO (1)	WO2005067937A1 (pl)
ZA (1)	ZA200605549B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120034193A1 (en) *	2009-01-24	2012-02-09	Daryl Rees	Treatment of neurotrophic factor mediated disorders
AR079059A1 (es)	2009-12-07	2011-12-21	Abbott Healthcare Products Bv	Acido ((3s)-3-(((1-(((2r)-2-carboxi-4-(1-naftil) butil) ciclopentil)-carbonil) amino )-2-oxo-2,3,4,5-tetrahidro-1h-1-benzazepin-1-il) acetico cristalino, su preparacion y uso
CN106065006B (zh) *	2015-04-22	2020-06-05	深圳信立泰药业股份有限公司	一种中性内肽酶抑制剂盐晶型及其制备方法
PL424453A1 (pl) *	2018-01-31	2019-08-12	Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością	Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
PL424452A1 (pl)	2018-01-31	2019-08-12	Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością	Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
CN110590695B (zh) *	2019-10-22	2023-03-21	南华大学	苯并氮杂环类化合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19510566A1 (de) *	1995-03-23	1996-09-26	Kali Chemie Pharma Gmbh	Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19750002A1 (de) *	1997-11-12	1999-05-20	Solvay Pharm Gmbh	Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
JP4350306B2 (ja) *	1998-04-23	2009-10-21	ノバルティスアクチエンゲゼルシャフト	エンドセリン変換酵素のチオール型阻害剤
US20020013307A1 (en) *	2000-05-23	2002-01-31	Pablo Lapuerta	Use of vasopeptidase inhibitors to treat or slow the progression of cognitive dysfunction and to treat and/or prevent dementia
US6505135B2 (en) *	2001-03-13	2003-01-07	Micro Motion, Inc.	Initialization algorithm for drive control in a coriolis flowmeter
AR039352A1 (es) *	2001-05-18	2005-02-16	Solvay Pharm Gmbh	Uso de un compuesto que tiene actividad inhibitoria combinada y concurrente con endopeptidasa neutra y metaloproteasa igs5.
CL2004000545A1 (es) *	2003-03-18	2005-01-28	Pharmacia Corp Sa Organizada B	Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul

2005
- 2005-01-10 PL PL05701469T patent/PL1706121T3/pl unknown
- 2005-01-10 CN CN2005800022847A patent/CN101076339B/zh not_active Expired - Fee Related
- 2005-01-10 SI SI200530457T patent/SI1706121T1/sl unknown
- 2005-01-10 WO PCT/EP2005/050075 patent/WO2005067937A1/en not_active Ceased
- 2005-01-10 RU RU2006129288/15A patent/RU2362563C2/ru active
- 2005-01-10 AT AT05701469T patent/ATE406899T1/de active
- 2005-01-10 ES ES05701469T patent/ES2313279T3/es not_active Expired - Lifetime
- 2005-01-10 AU AU2005205067A patent/AU2005205067B2/en not_active Ceased
- 2005-01-10 CA CA2551789A patent/CA2551789C/en not_active Expired - Fee Related
- 2005-01-10 EP EP05701469A patent/EP1706121B1/en not_active Expired - Lifetime
- 2005-01-10 DK DK05701469T patent/DK1706121T3/da active
- 2005-01-10 BR BRPI0506750-2A patent/BRPI0506750A/pt not_active Application Discontinuation
- 2005-01-10 HR HR20080611T patent/HRP20080611T3/xx unknown
- 2005-01-10 JP JP2006548311A patent/JP4951350B2/ja not_active Expired - Fee Related
- 2005-01-10 DE DE602005009487T patent/DE602005009487D1/de not_active Expired - Lifetime
- 2005-01-10 PT PT05701469T patent/PT1706121E/pt unknown
- 2005-10-01 UA UAA200609032A patent/UA82008C2/uk unknown
2006
- 2006-06-21 IL IL176456A patent/IL176456A/en active IP Right Grant
- 2006-07-05 ZA ZA200605549A patent/ZA200605549B/xx unknown
- 2006-08-10 NO NO20063623A patent/NO20063623L/no not_active Application Discontinuation
- 2006-08-11 KR KR1020067016297A patent/KR101219580B1/ko not_active Expired - Fee Related
2008
- 2008-11-24 CY CY20081101348T patent/CY1108588T1/el unknown

Also Published As

Publication number	Publication date
BRPI0506750A (pt)	2007-05-22
ATE406899T1 (de)	2008-09-15
CA2551789A1 (en)	2005-07-28
WO2005067937A1 (en)	2005-07-28
IL176456A (en)	2010-03-28
KR101219580B1 (ko)	2013-01-08
AU2005205067B2 (en)	2009-10-22
RU2362563C2 (ru)	2009-07-27
PT1706121E (pt)	2008-12-04
KR20060123541A (ko)	2006-12-01
DE602005009487D1 (de)	2008-10-16
JP4951350B2 (ja)	2012-06-13
NO20063623L (no)	2006-10-12
JP2007517834A (ja)	2007-07-05
PL1706121T3 (pl)	2009-02-27
CN101076339A (zh)	2007-11-21
EP1706121A1 (en)	2006-10-04
CA2551789C (en)	2011-05-03
IL176456A0 (en)	2006-10-05
HRP20080611T3 (hr)	2008-12-31
UA82008C2 (uk)	2008-02-25
ES2313279T3 (es)	2009-03-01
SI1706121T1 (sl)	2009-02-28
AU2005205067A1 (en)	2005-07-28
EP1706121B1 (en)	2008-09-03
RU2006129288A (ru)	2008-02-20
CY1108588T1 (el)	2014-04-09
ZA200605549B (en)	2007-12-27
CN101076339B (zh)	2011-02-09

Publication	Publication Date	Title
MX2012001985A (es)	2012-02-29	Derivados de 3-amino-5-fenil-5,6-dihidro-2h-[1,4]oxazina.
GEP20125565B (en)	2012-07-10	Lactam compounds and their pharmaceutical use
WO2008079291A3 (en)	2008-11-06	Substituted heterocycles and methods of use
WO2005070891A3 (en)	2005-10-20	Compounds and methods of use
WO2007058602A3 (en)	2007-07-05	Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
WO2007058583A3 (en)	2007-07-05	Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
WO2005066163A3 (en)	2005-09-01	Thiophene derivatives as chk 1 inihibitors
MY144992A (en)	2011-12-15	Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
WO2005004818A3 (en)	2005-05-06	Heterocyclic compounds and their use as anticancer agents
IN2012DN03043A (pl)	2015-07-31
WO2008076046A8 (en)	2008-11-06	Novel 2-amino-5, 5-diaryl-imidazol-4-ones
NO20060324L (no)	2006-05-18	[1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni
WO2006011050A3 (en)	2006-10-05	Pyridine derivatives
WO2006099943A8 (de)	2006-11-09	Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2005040171A8 (en)	2006-08-03	Pyrazolo and imidazo-pyrimidine derivatives
PL1682528T3 (pl)	2008-01-31	Pochodne benzo[b][1,4]dioksepiny
WO2005061467A3 (en)	2006-06-01	Piperazine derivatives as bradykinin antagonists
CY1108588T1 (el)	2014-04-09	ΑΝΑΣΤΟΛΕΙΣ ΟΥΔΕΤΕΡΗΣ ΕΝΔΟΠΕΠΤΙΔΑΣΗΣ (ΝΕΡ) ΚΑΙ ΑΝΘΡΩΠΙΝΗΣ ΔΙΑΛΥΤΗΣ ΕΝΔΟΠΕΠΤΙΔΑΣΗΣ (hSEP) ΓΙΑ ΤΗΝ ΠΡΟΦΥΛΑΞΗ ΚΑΙ ΘΕΡΑΠΕΙΑ ΝΕΥΡΟΕΚΦΥΛΙΣΤΙΚΩΝ ΠΑΘΗΣΕΩΝ
WO2005080345A3 (en)	2006-12-21	Imidazoline derivatives having cb1-antagonistic activity
WO2007111983A8 (en)	2007-12-21	New therapeutic combinations for the treatment or prevention of psychotic disorders
WO2008152068A3 (en)	2009-05-07	[1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
WO2005055943A3 (en)	2005-08-18	Vinorelbine derivatives
WO2008033935A3 (en)	2008-11-06	Vinorelbine derivatives
WO2008033930A3 (en)	2008-11-13	Vinca derivatives
GB0407025D0 (en)	2004-04-28	Novel compounds